Review



cylex® stimulated atp  (Cylex Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cylex Inc cylex® stimulated atp
    Explorations of potential predictors of clinical deterioration at week 16 as measured by change in KPSI to week 16
    Cylex® Stimulated Atp, supplied by Cylex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cylex® stimulated atp/product/Cylex Inc
    Average 90 stars, based on 1 article reviews
    cylex® stimulated atp - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes"

    Article Title: A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes

    Journal: Journal of Neurovirology

    doi: 10.1007/s13365-013-0173-y

    Explorations of potential predictors of clinical deterioration at week 16 as measured by change in KPSI to week 16
    Figure Legend Snippet: Explorations of potential predictors of clinical deterioration at week 16 as measured by change in KPSI to week 16

    Techniques Used: Clinical Proteomics



    Similar Products

    cylex® stimulated atp  (Cylex Inc)
    90
    Cylex Inc cylex® stimulated atp
    Explorations of potential predictors of clinical deterioration at week 16 as measured by change in KPSI to week 16
    Cylex® Stimulated Atp, supplied by Cylex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cylex® stimulated atp/product/Cylex Inc
    Average 90 stars, based on 1 article reviews
    cylex® stimulated atp - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Explorations of potential predictors of clinical deterioration at week 16 as measured by change in KPSI to week 16

    Journal: Journal of Neurovirology

    Article Title: A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes

    doi: 10.1007/s13365-013-0173-y

    Figure Lengend Snippet: Explorations of potential predictors of clinical deterioration at week 16 as measured by change in KPSI to week 16

    Article Snippet: The following variables of interest were tested for their potential correlation or association to KPSI change from baseline to week 16; except where specified, both baseline and change from baseline at week 4 results were tested: KPSI score (<50 vs ≥50, baseline only), EDSS score (<6.0 vs ≥6.0, baseline only), log 10 JCV DNA load in CSF, log 10 JCV DNA load in plasma, log 10 JCV DNA load in urine, CD3 + /CD4 + FACS count, CD3 + /CD8 + FACS count, Cylex® stimulated ATP, HIV RNA PCR, presence of Gd + lesions, T2 volume, SDMT, and VAS.

    Techniques: Clinical Proteomics